Mucin-positive epithelial mesotheliomas: A histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas

Ultrastructural Pathology

Volumn 20, Issue 4, 1996, Pages 293-325

  Hammar, Samuel P ^a   Bockus, Dawn E ^a   Remington, Franque L ^a   Rohrbach, Kathy A ^a  

^a Diagnostic Specialties Laboratory Inc   (United States)

Author keywords

epithelial mesothelioma; histochemistry; hyaluronic acid proteoglycan crystals; immunohistochemistry electron microscopy; mucin; pulmonary adenocarcinoma

Indexed keywords

HYALURONIC ACID; MUCIN; PROTEOGLYCAN;

ARTICLE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTAL; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0029790279     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129609016331     Document Type: Article

References (40)

1. Hammar SP. Pleural diseases. In: Dail DH, Hammar SP, eds. Pulmonary Pathology, 2d ed. New York: Springer; 1994:1487-1579.
2. Wick MR, Loy T, Mills SE, Legier JF, Manivel JC. Malignant epithelioid pleural mesothelioma versus peripheral adenocarcinoma: a histochemical, ultrastructural and immunohistologic study of 103 cases. Hum Pathol. 1990;21-759-766.
3. Benjamin CJ, Ritchie AC. Histological staining for the diagnosis of mesothelioma. Am J Med Technol. 1982;48:905-908.
4. Ernst CS, Atkinson BF. Mucicarmine positivity in malignant mesothelioma. Lab Invest. 1980;42:113-114.
5. MacDougall DB, Wang SE, Zibar BL. Mucin-positive epithelial mesothelioma. Arch Pathol Lab Med. 1992;116: 874-880.
6. Merger J, Lamerz R, Permanether W. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J Thorac Cardiovasc Surg. 1990;100:860-866.
7. Otis CN, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma: a bi-institutional study of 47 cases. Am J Surg Pathol. 1987;11:445-456.
8. Robb JA. Mesothelioma versus adenocarcinoma: false positive CEA and LeuM1 staining due to hyaluronic acid. Hum Pathol. 1989;20:400.
9. Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shuh AR, Wick MR. Immunoreactivity for BerEP4 in adenocarcinoma, adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol. 1992;16:593-599.
10. Harwood TR, Gracey DR, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol. 1976;65:159-167.
11. Koss M, Travis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol. 1992;9:117-123.
12. Robb JA, Hammar SP, Yokoo H. Pseudomesotheliomatous lung carcinoma: a rare asbestos-related malignancy readily separable from epithelial pleural mesothelioma. Hum Pathol. In press.
13. Hammar SP. The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms. In: MacKay B, ed. Diagnostic Electron Microscopy of Tumors. New York: Saunders; 1987:1-230.
14. Henderson DW. Papadimitriou JM, Coleman M. Ultrastructural Appearances of Tumors. 2d ed. Edinburgh: Churchill Livingstone; 1986:42-112.
15. Burns TR, Johnson EH, Cartwright J Jr, Greenberg SD. Desmosomes of epithelial malignant mesotheliomas. Ultrastruct Pathol. 1988;12:385-388.
16. Dewar A, Valente M, Ring NP, Corrin B. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol. 1987;152:309-316.
17. Coleman M, Henderson DW, Mukherjee TM. The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu. 1989;24:303-353.
18. Ghadially FN, McCaughey WTE, Perkins DG, Rippstein P. Diagnostic value of microvillus-matrix associations in tumors. J Submicrosc Cytol Pathol. 1992;24:103-108.
19. Ghadially FN, McCaughey WTE, Perkins DG, Rippstein P, Jeans D. Morphogenesis and frequency of microvillusmatrix associations in mesotheliomas and adenocarcinomas. MSA Bull. 1993;23:281-287.
20. Ghadially FN. Diagnostic value of some matrix components. Ultrastruct Pathol. 1992;16:221-230.
21. Graeme-Cook F, Mark EJ. Pulmonary mucinous cystic tumors of borderline malignancy. Hum Pathol. 1991;22:185-190.
22. Hammar SP. Common neoplasms. In: Dail DH, Hammar SP, eds. Pulmonary Pathology, 2d ed. New York: Springer; 1994:1123-1278.
23. Albernet R, Jageux M, Fondimare A, et al. Les mesotheliomes pleuraux. Rev Fr Mal Resp. 1979;7:243-264.
24. Culling DFA, Reid PE, Burton JD, et al. A histochemical method of differentiating lower gastrointestinal tract tumors. J Clin Pathol. 1975;28:656-658.
25. Henderson DW, Shilkin KB, Whitaker D, Attwood HD, Constance TJ, Steele RH, Leppard PJ. The pathology of malignant mesothelioma, including immunohistology and ultrastructure. In: Henderson DW, Shilkin KG, Langlois SLD, Whitaker D, eds. Malignant Mesothelioma. New York: Hemisphere; 1992:69-139.
26. Walz R, Koch HK. Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis: histological and immunohistochemical evaluation and followup of mesotheliomas diagnosed from 1964 to January 1985. Pathol Res Prac. 1990;186:124-134.
27. Roggli VL, Kolbeck J, Sanfilippo F, Shelburne JD. Pathology of human mesothelioma: etiology and diagnostic considerations. Pathol Annu. 1987;22(part 2):91-131.
28. Brown RW, Clark CM, Tandon AK, Allread DC. Multiple-marker immunohistochemical phenotype distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol. 1993;24:347-354.
29. Loosli H, Hurlimann J. Immunohistological study of malignant diffuse mesothelioma of the pleura. Histopathology. 1984;8:793-803.
30. Iozzo RV, Goldes JA, Chen W-J, Wight TN. Glycosaminoglycans of pleural mesothelioma: a possible biochemical variant containing chondroitin sulfate. Cancer. 1981;48: 89-97.
31. Nakano T, Fujii J, Tamura S, et al. Glycosaminoglycan in malignant pleural mesothelioma. Cancer. 1986;57:106-110.
32. Waxler B, Eisenstein R, Battifora H. Electrophoresis of tissue glycosaminoglycans as an aid in the diagnosis of mesothelioma. Cancer. 1979;44:221-227.
33. Yung S, Thomas GJ, Stylianov E, Williams JD, Coles GA, Davies M. Source of peritoneal proteoglycans: human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol. 1995; 146:520-529.
34. Sandell LJ. Molecular biology of proteoglycans and link proteins. In: Wight TN, Mecham RP, eds. Biology of Proteoglycans. Orlando: Academic; 1987:27-57.
35. Caterson B, Calabro T, Hampton A. Monoclonal antibodies as probes for elucidating proteoglycan structure and function. In: Wight TN, Mecham RP, eds. Biology of Proteoglycans. Orlando: Academic; 1987:1-25.
36. Holland ND, Holland LZ. Fine structures of the mesothelia and extracellular materials in the coelomic fluid of fin boxes, myocoels and sclerocoels of a lancet. Branchiostoma floridae (Cephalochordata = Acrania). Acta Zool (Stockholm). 1990;71;225-234.
37. Henderson DW, Leppard PJ, Howard MJ. The diagnostic fine structure of malignant mesothelioma. Proceedings of the World Health Organization Bi-Regional Training Course of Electron Microscopy in BioMedical Research and Diagnosis of Human Diseases, Bangkok, Thailand, 28 October-1 November, 1991.
38. Kawai T, Suzuki M, Kageyama K. Glycosaminoglycans in lung carcinoma. Hum Pathol. 1988;19:1288-1292.
39. Hammar SP, Bockus D, Remington F, Bartha M. The widespread distribution of Langerhans cells in pathologic tissue: an ultrastructural and immunohistochemical study. Hum Pathol. 1986;17:894-905.
40. Friedman HD, Litovsky SH, Abraham JL. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma. Arch Pathol Lab Med. 1993;117:967.